BindingDB logo
myBDB logout

null

SMILES: C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(F)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO

InChI Key: InChIKey=GNZBRCVHYABOOV-KDURUIRLSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 476696   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Dimer of Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM476696
PNG
(2-((2R,6S)-4-(3-((5-chloro-4-(6-fluoro-1H-indole-3...)
Show SMILES C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(F)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO
Show InChI InChI=1S/C30H34ClFN6O/c1-18-15-37(16-19(2)38(18)7-8-39)17-20-9-22(21-3-4-21)11-24(10-20)35-30-34-14-27(31)29(36-30)26-13-33-28-12-23(32)5-6-25(26)28/h5-6,9-14,18-19,21,33,39H,3-4,7-8,15-17H2,1-2H3,(H,34,35,36)/t18-,19+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a 8.10n/an/an/an/an/an/a


TBA



Citation and Details
More data for this
Ligand-Target Pair
Dimer of Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM476696
PNG
(2-((2R,6S)-4-(3-((5-chloro-4-(6-fluoro-1H-indole-3...)
Show SMILES C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(F)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO
Show InChI InChI=1S/C30H34ClFN6O/c1-18-15-37(16-19(2)38(18)7-8-39)17-20-9-22(21-3-4-21)11-24(10-20)35-30-34-14-27(31)29(36-30)26-13-33-28-12-23(32)5-6-25(26)28/h5-6,9-14,18-19,21,33,39H,3-4,7-8,15-17H2,1-2H3,(H,34,35,36)/t18-,19+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.10n/an/an/an/an/an/a



HANMI PHARM. CO.. LTD.

US Patent


Assay Description
The inhibitory activity of some of the compounds described above against FLT3-ITD, FLT3 wild type (WT), VEGFR2 (KDR), and SYK kinase was measured.The...


US Patent US10870639 (2020)

More data for this
Ligand-Target Pair